BKM120 as Second-line Therapy for Advanced Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.
- Status
- COMPLETED
- Phase
- PHASE3
BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
The Gilenya Pregnancy Registry
- Status
- COMPLETED
- Phase
- N/A
A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Observational Registry Study of Renal Transplant Patients
- Status
- WITHDRAWN
- Phase
- N/A
Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.
- Status
- COMPLETED
- Phase
- PHASE2
A Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Improving the Efficacy of Anti-Nicotine Immunotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function
- Status
- TERMINATED
- Phase
- PHASE1
A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE4
Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1